Label on lupus nephritis therapy Lupkynis adds long-term efficacy data
The FDA has updated the prescribing label for Lupkynis to show that it continues to safely preserve kidney function for up to three years.| Lupus News Today
The FDA has updated the prescribing label for Lupkynis to show that it continues to safely preserve kidney function for up to three years.| Lupus News Today
A CAR T-cell therapy cleared disease-causing autoantibodies from the bloodstream of eight SLE patients without compromising vaccine response.| Lupus News Today
